Screener
Bioventus BVS Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | June 27, 2026 | December 31, 2025 |
|---|---|---|
| Accrued liabilities | 109,361 | 130,242 |
| Current portion of long-term debt | 18,750 | 15,000 |
| Other current liabilities | 4,144 | 4,210 |
| Total current liabilities | 152,451 | 160,380 |
| Long-term debt, less current portion | 229,702 | 278,951 |
| Deferred income tax liabilities | 568 | 433 |
| Other long-term liabilities | 13,213 | 15,348 |
| Total liabilities | 395,934 | 455,112 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's total current liabilities?
- Bioventus (BVS) reported total current liabilities of $152.45M in Q2 2026.
- How has Bioventus's total current liabilities changed year-over-year?
- Bioventus's total current liabilities decreased by 17.9% year-over-year, from $185.68M to $152.45M.
- What is the long-term trend for Bioventus's total current liabilities?
- Over 5 years (2020 to 2025), Bioventus's total current liabilities has grown at a 5.5% compound annual growth rate (CAGR), from $122.59M to $160.38M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Bioventus's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude